Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone: Analysis of the Austrian head and neck cancer registry of the AGMT

BACKGROUND: The addition of cisplatin or cetuximab to radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) has significantly improved the outcome. While the superiority of cisplatin over cetuximab in combination with radiotherapy has been shown in a def...

Descripción completa

Detalles Bibliográficos
Autores principales: Magnes, Teresa, Wagner, Sandro M., Melchardt, Thomas, Weiss, Lukas, Rinnerthaler, Gabriel, Huemer, Florian, Kopp, Michael, Gampenrieder, Simon Peter, Mayrbäurl, Beate, Füreder, Thorsten, Lenger, Daniel, Andel, Johannes, Egle, Alexander, Greil, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599358/
https://www.ncbi.nlm.nih.gov/pubmed/34528125
http://dx.doi.org/10.1007/s00508-021-01939-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599358/
https://www.ncbi.nlm.nih.gov/pubmed/34528125
http://dx.doi.org/10.1007/s00508-021-01939-3

Ejemplares similares